Follow-up period | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1 month | 3 months | 6 months | 12 months | 24 months | ||||||
Outcome | FMI | MD | FMI | MD | FMI | MD | FMI | MD | FMI | MD |
SF-36 PCS | 11.9 | 15.7 | 15.8 | 22.3 | 17.2 | 23.7 | 23.9 | 27.7 | 30.1 | 30.0 |
EQ-5D | 14.5 | 15.3 | 13.1 | 21.7 | 18.0 | 23.0 | 18.4 | 27.0 | 20.9 | 27.7 |
RMD | 9.9 | 17.3 | 19.8 | 26.7 | 18.2 | 28.3 | 21.0 | 33.7 | 19.9 | 37.7 |
Back pain | 12.3 | 12.7 | 15.7 | 18.7 | 19.0 | 20.3 | 17.3 | 25.3 | 29.6 | 25.0 |
Restricted activity | 9.6 | 22.0 | 14.0 | 26.3 | 19.6 | 26.0 | 19.3 | 30.0 | 20.0 | 32.3 |
Days in bed | 21.2 | 18.7 | 24.6 | 24.0 | 27.5 | 24.0 | 35.4 | 28.0 | 34.3 | 30.3 |